Navigation Links
MediPoint: Total Hip Replacement - EU Analysis and Market Forecasts
Date:11/5/2013

London (PRWEB) November 05, 2013

Summary

Osteoarthritis has become a global public health concern with no cure. It is the most common form of arthritis that is primarily due to wear and tear of the joints. With the aging global population, this is an indication that is growing rapidly with the hip being one of the most common joints afflicted. While the primary indication for total hip replacement (THR) is osteoporosis, the other major indications for THR are osteonecrosis and fractures to a lesser degree. As people live longer and with younger patients also receiving implants, the revision rates for primary hip replacements are also expected to rise. Primary hip replacement has become one of the most successful surgeries, with a variety of femoral and acetabular components available from a wide selection of manufacturers. This report focuses on the total primary hip replacement market along with primary revision market. The global hip replacement market has been estimated in this report which includes France, Germany, Italy, Spain, UK. The report provides unmet needs, future adoption and compounded annual growth rates (CAGR). GlobalData’s analysis shows that the hip replacement market has become a mature market where products have become commodities. The future of the market lays on the ability of manufacturers to provide implants at a very low cost while continuing to provide the same level of clinical efficacy. The product development need lies primarily in revising the resurfacing products’ articulating surface with new materials rather than developing new acetabular and femoral components. Additionally the major opportunity lies within the emerging markets which are the countries that have a higher CAGR and will provide the key for growth and grabbing market share.

Scope

-An overview of Osteoarthritis, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. '/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. MediPoint: In-Vitro Colorectal Cancer Screening Tests - APAC Analysis and Market Forecasts
2. MediPoint: In-Vitro Colorectal Cancer Screening Tests - US Analysis and Market Forecasts
3. MediPoint: In-Vitro Colorectal Cancer Screening Tests - EU Analysis and Market Forecasts
4. MediPoint: Hernia Repair - South American Analysis and Market Forecasts
5. MediPoint: Total Hip Replacement - US Analysis and Market Forecasts
6. MediPoint: Hernia Repair - APAC Analysis and Market Forecasts
7. MediPoint: Hernia Repair - EU Analysis and Market Forecasts
8. MediPoint: Hernia Repair - US Analysis and Market Forecasts
9. Total hospital cost of robotic or conventional open-chest mitral valve repair surgery is similar
10. Upgraded Dragon Medical Practice Edition 2 Being Offered by Total Voice Technologies with Special Pricing Incentive
11. Total Wellness Cleanse Detox Diet Review Discloses the Secrets to Full Body Detoxification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... PA (PRWEB) October 02, 2014 ... of the 2014 BIG Awards for Business program. ... and organizations with a proprietary judging process scored ... around the globe. , “The winners this year ... Russ Fordyce, Managing Director of the Business Intelligence ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, ... a neurotic personality style and prolonged stress may have ... suggests. Tracking 800 women over nearly four decades, ... jealous and moody -- which they defined as neurotic ... of developing Alzheimer,s compared to women scoring lowest in ...
(Date:10/2/2014)... By Steven Reinberg ... -- Living close to a major highway may raise your ... Among more than 5,000 postmenopausal women, those who lived within ... greater risk of developing high blood pressure than women living ... "The results of this study highlight the importance of our ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. 1, 2014 (HealthDay ... have a total of 500 confirmed cases of Enterovirus D68, ... since the summer, U.S. health officials reported Wednesday. Four ... but it,s not clear what role -- if any -- ... officials are also trying to determine if the virus is ...
(Date:10/1/2014)... team of scientists has shown that more than 80 ... existing drugs. , The study found that medicines called ... a genetic mutation that is present in more than ... are currently used, or are in clinical trials, for ... disorders. , Bowel cancer is the second-most common cancer ...
Breaking Medicine News(10 mins):Health News:Innovation Dominant Theme among 2014 Big Awards for Business Winners and Finalists 2Health News:Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says 2Health News:Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says 3Health News:Living Near a Highway May Be Bad for Your Blood Pressure 2Health News:Living Near a Highway May Be Bad for Your Blood Pressure 3Health News:42 States Reporting Respiratory Virus That Targets Kids 2Health News:42 States Reporting Respiratory Virus That Targets Kids 3Health News:Eighty percent of bowel cancers halted with existing medicines 2
... movement, study finds, , , WEDNESDAY, Feb. 18 (HealthDay News) ... of their impaired physical abilities, even if it,s been ... paralysis on the right side after a stroke were ... hold and move objects after they participated in robot-assisted ...
... finds misdiagnosis risk goes up as age goes down , , ... of numbness at a Detroit emergency room was discharged after ... woman with sharp pain in her left eye and loss ... doctors that she had a migraine. , And a 29-year-old ...
... health complications , during National Eating Disorders Awareness WeekLISLE, ... wants to call attention to the dangers surrounding ... treatment during National Eating Disorders Awareness Week -- Feb. ... concern and can cause a variety of oral health ...
... this week,s Journal of the American Medical,Association ... of Bioinformatics at the National Institute of Statistical Sciences, ... statistical limitations of a study,claiming that bisphenol A is ... liver,enzyme levels. The earlier study, published in JAMA ...
... 18 Specialty Underwriters,Alliance, Inc. (Nasdaq: SUAI ... on Friday, March 6, 2009 at 11:00 a.m. Eastern ... year end results for 2008. Detailed,financial information will ... 2009. , Interested parties may ...
... Feb. 18 Monthly menstrual cycles ... can include cramps, headaches and bloating. With more ... dysmenorrhea, regular vomiting also is a symptom. This ... to a study in the November/December 2008 issue ...
Cached Medicine News:Health News:Working With Robots May Help After a Stroke 2Health News:ER Less Likely to Diagnose Stroke in Younger Folks 2Health News:ER Less Likely to Diagnose Stroke in Younger Folks 3Health News:Dentists Often First to Spot Eating Disorders in Patients 2Health News:Dentists Often First to Spot Eating Disorders in Patients 3Health News:Specialty Underwriters' Alliance, Inc. Announces Fourth Quarter and Year End 2008 Conference Call 2Health News:Women Only: Cramps, Bloating and Now, Tooth Erosion? 2Health News:Women Only: Cramps, Bloating and Now, Tooth Erosion? 3
(Date:10/2/2014)... Echo Therapeutics, Inc. (NASDAQ: ECTE ... recent unauthorized public statements relating to Echo that have ... Shepard M. Goldberg, two members of the Echo Board ... the Echo Board by an affiliate of Platinum Management ... in numerous unauthorized public communications targeted at Echo stockholders, ...
(Date:10/2/2014)... 2014  Eli Lilly and Company (NYSE: LLY)  ... -- being studied for the treatment of systemic ... due to insufficient efficacy in two pivotal Phase ... safety concerns. ­­­­ In the ILLUMINATE ... endpoint, at either dose studied, of statistically significant ...
(Date:10/2/2014)... plc (NYSE: PRGO ; TASE), a public limited ... (the " Company "), today announced the expiration of ... of its new 1.30% Senior Notes due 2016 (the " ... Notes due 2018 (the " 2018 Exchange Notes "), $800,000,000 ... 2023 Exchange Notes ") and $400,000,000 of its new 5.30% ...
Breaking Medicine Technology:Echo Therapeutics Comments On Unauthorized Public Statements By Michael M. Goldberg, M.D. And Shepard M. Goldberg 2Echo Therapeutics Comments On Unauthorized Public Statements By Michael M. Goldberg, M.D. And Shepard M. Goldberg 3Echo Therapeutics Comments On Unauthorized Public Statements By Michael M. Goldberg, M.D. And Shepard M. Goldberg 4Lilly to Discontinue Development of Tabalumab Based on Efficacy Results in Phase 3 Lupus Studies 2Lilly to Discontinue Development of Tabalumab Based on Efficacy Results in Phase 3 Lupus Studies 3Perrigo Company plc Announces Expiration Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 2Perrigo Company plc Announces Expiration Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 3Perrigo Company plc Announces Expiration Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 4
... 5, 2007 - Australian,biotechnology company Avexa (ASX:AVX) announced ... which,represents the first 24 week segment of its ... open-label section of the,trial (weeks 24 to 48) ... day as part of their daily treatment regime.,The ...
... Primary endpoint achieved -- , LAINATE, Italy - ... today positive preliminary results from its,phase II/III study ... is a broad spectrum, semi-synthetic,antibiotic that is not ... of Cosmo's MMX(tm) technology, which delivers the active,ingredient ...
Cached Medicine Technology:Avexa's Apricitabine Clinical Trial Update 2Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III,Data with Rifamycin MMX in Infectious Diarrhea 2
Diamond Point Bone Probe with Ortho-Grip® silicone rubber palm style handles and,stainless steel impactor caps....
The AV Plus DX pacing lead is designed for use with the St. Jude Medical Affinity VDR pulse generator. This single-lead pacing system provides reliable pacing therapy with the added benefits of AV sy...
Steroid eluting pacemaker leads...
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
Medicine Products: